Journal for ImmunoTherapy of Cancer | |
Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome | |
David R Schwartz1  Elad Sharon2  Diana Esaian1  Roy A Raad1  Benjamin P Geisler1  | |
[1] New York University School of Medicine, New York 10016, NY, USA;National Cancer Institute, Bethesda 20892, MD, USA | |
关键词: Drug-related side effects and adverse reactions; Melanoma; Ipilimumab [Supplementary concept]; Takotsubo cardiomyopathy; | |
Others : 1133480 DOI : 10.1186/s40425-015-0048-2 |
|
received in 2014-08-14, accepted in 2015-02-03, 发布年份 2015 | |
【 摘 要 】
Although animal studies have shown that the immunomodulator ipilimumab causes inflammation of the myocardium, clinically significant myocarditis has been observed only infrequently. We report a case of suspected acute coronary syndrome without a culprit lesion on cardiac angiography and takotsubo cardiomyopathy (TC)-like appearance on echocardiography in a patient with metastatic melanoma who received four standard doses of ipilimumab. Apical ballooning, hyperdynamic basal wall motion, systolic anterior motion of the mitral valve, and associated severe left ventricular outflow tract obstruction were present. Restaging with positron emission tomography-computed tomography done soon after discharge incidentally revealed increased fludeoxyglucose uptake in the apex. This case illustrates that a TC-like syndrome might be caused by autoimmune myocarditis after ipilimumab treatment although this was not biopsy-confirmed. Post-marketing surveillance should capture cardiac events occurring in patients treated with ipilimumab to better document and clarify a relationship to the drug, and biopsies should be considered. Physicians utilizing this novel agent should be aware of the potential for immune-related adverse events.
【 授权许可】
2015 Geisler et al.; licensee BioMed Central.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150304161448306.pdf | 3394KB | download | |
Figure 2. | 45KB | Image | download |
Figure 1. | 37KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
【 参考文献 】
- [1]Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, et al.: Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010, 55:333-41.
- [2]Izumi Y: Drug-induced takotsubo cardiomyopathy. Heart failure clinics 2013, 9:225-31.
- [3]Smith SA, Auseon AJ: Chemotherapy-induced takotsubo cardiomyopathy. Heart failure clinics 2013, 9:233-42.
- [4]Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al.: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010, 363:711-23.
- [5]Weber JS, Kahler KC, Hauschild A: Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol Off J Am Soc Clin Oncol 2012, 30:2691-7.
- [6]Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3:541-7.
- [7]Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al.: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-8.
- [8]Fellner C: Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use. P & T: a peer-reviewed journal for formulary management 2012, 37:503-30.
- [9]Prasad A, Lerman A, Rihal CS: Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008, 155:408-17.
- [10]Caforio AL, Tona F, Vinci A, Calabrese F, Ramondo A, Cacciavillani L, et al.: Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail 2009, 11:428-31.
- [11]Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, et al.: The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 2006, 66:845-51.
- [12]Yoshida T, Hibino T, Kako N, Murai S, Oguri M, Kato K, et al.: A pathophysiologic study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography. Eur Heart J 2007, 28:2598-604.
- [13]Cimarelli S, Imperiale A, Ben-Sellem D, Rischner J, Detour J, Morel O, et al.: Nuclear medicine imaging of takotsubo cardiomyopathy: typical form and midventricular ballooning syndrome. J Nucl Cardiol 2008, 15:137-41.
- [14]Miyachi H, Kumita S, Tanaka K: PET/CT and SPECT/CT cardiac fusion imaging in a patient with takotsubo cardiomyopathy. Eur Heart J 2013, 34:397.
- [15]Ozawa K, Funabashi N, Daimon M, Takaoka H, Takano H, Uehara M, et al.: Determination of optimum periods between onset of suspected acute myocarditis and (1)(8)F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium. Int J Cardiol 2013, 169:196-200.
- [16]Kontozis L, Soteriou M, Papamichael D, Economides C, Bagdades E, Christou C, et al.: Isolated right atrial metastasis of malignant melanoma mimicking a myxoma. Hellenic J Cardiol 2011, 52:281-4.